US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

14.910
+0.140+0.95%

Close Nov 29 13:00 ET

14.910
0.0000.00%

Post 13:02 ET

384.35MMarket Cap-13276P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-14.73%-6.17M

-120.90%-8.5M

-52.08%-7.98M

196.16%19.35M

-162.61%-10.7M

-5.38M

40.67M

-5.24M

23.40%-20.12M

-4.08M

Net income from continuing operations

-64.25%-10.27M

-121.68%-9.01M

-74.48%-8.42M

193.68%22.72M

-3.42%-7.77M

---6.25M

--41.56M

---4.82M

16.37%-24.25M

---7.51M

Operating gains losses

----

387.50%117K

300.00%14K

-166.67%-8K

---2K

--0

--24K

-250.00%-7K

---3K

Depreciation and amortization

44.19%62K

42.86%60K

-16.44%61K

-40.73%195K

-54.32%37K

--43K

--42K

--73K

1.23%329K

--81K

Other non cash items

-1.28%231K

112.26%351K

-7.58%244K

-172.46%-2.1M

-89.65%265K

--234K

---2.86M

--264K

1,667.07%2.9M

--2.56M

Change In working capital

107.15%2.32M

-112.58%-209K

127.12%275K

19.18%-1.02M

-765.87%-2.79M

--1.12M

--1.66M

---1.01M

-1,273.15%-1.27M

--419K

-Change in prepaid assets

135.11%435K

189.13%133K

1,288.33%713K

-237.83%-1.28M

-131.17%-24K

---1.24M

--46K

---60K

-0.53%-378K

--77K

-Change in payables and accrued expense

-30.26%1.87M

-170.16%-1.29M

35.34%-450K

2,244.12%1.59M

-450.63%-2.23M

--2.68M

--1.84M

---696K

-80.90%68K

--636K

-Change in other current assets

101.67%1K

3,127.59%936K

--0

121.88%7K

203.13%33K

---60K

--29K

--5K

-300.00%-32K

---32K

-Change in other current liabilities

104.96%13K

105.12%13K

104.56%12K

-45.73%-1.35M

19.63%-569K

---262K

---254K

---263K

-925.89%-925K

---708K

Cash from discontinued investing activities

Operating cash flow

-14.73%-6.17M

-120.90%-8.5M

-52.08%-7.98M

196.16%19.35M

-162.55%-10.7M

---5.38M

--40.67M

---5.24M

23.40%-20.12M

---4.08M

Investing cash flow

Cash flow from continuing investing activities

23.58%-30.18M

12.50%-38.9M

-6.67%8.73M

-394.04%-65.57M

83.65%9.03M

-39.5M

-44.46M

9.36M

134.32%22.3M

4.92M

Net PPE purchase and sale

-181.82%-62K

-283.87%-119K

-182.69%-147K

-250.85%-414K

---309K

---22K

---31K

---52K

29.76%-118K

--0

Net investment purchase and sale

23.69%-30.12M

12.71%-38.78M

-5.62%8.88M

-390.65%-65.15M

89.93%9.34M

---39.47M

---44.43M

--9.41M

134.59%22.42M

--4.92M

Cash from discontinued investing activities

Investing cash flow

23.58%-30.18M

12.50%-38.9M

-6.67%8.73M

-394.04%-65.57M

83.65%9.03M

---39.5M

---44.46M

--9.36M

134.32%22.3M

--4.92M

Financing cash flow

Cash flow from continuing financing activities

-99.87%13K

131.60%108.36M

97.08%-18K

4,633.98%56.18M

48.64%-321K

10.33M

46.79M

-617K

-101.55%-1.24M

-625K

Net issuance payments of debt

--0

-200.00%-3.75M

--0

---3.13M

---625K

---1.25M

---625K

Net common stock issuance

--0

----

-600.00%-28K

---28K

--0

----

---4K

--0

Net preferred stock issuance

--0

----

--60.14M

--0

--10.24M

----

--0

Proceeds from stock option exercised by employees

-84.15%13K

-31.58%13K

1,425.00%122K

960.00%159K

--50K

--82K

--19K

--8K

-86.73%15K

--0

Net other financing activities

----

---140K

---343K

----

Cash from discontinued financing activities

Financing cash flow

-99.87%13K

131.60%108.36M

97.08%-18K

4,633.98%56.18M

48.64%-321K

--10.33M

--46.79M

---617K

-101.55%-1.24M

---625K

Net cash flow

Beginning cash position

48.32%77.23M

79.45%16.26M

178.79%15.53M

20.28%5.57M

227.25%17.52M

--52.07M

--9.06M

--5.57M

-71.11%4.63M

--5.35M

Current changes in cash

-5.18%-36.34M

41.76%60.97M

-78.88%738K

960.38%9.96M

-1,027.91%-2M

---34.55M

--43.01M

--3.49M

108.24%939K

--215K

End cash Position

133.38%40.89M

48.32%77.23M

79.45%16.26M

178.79%15.53M

--17.52M

--52.07M

--9.06M

20.28%5.57M

--5.57M

Free cash flow

-15.78%-6.25M

-121.20%-8.62M

-53.36%-8.12M

193.56%18.94M

-170.13%-11.01M

---5.4M

--40.64M

---5.3M

23.44%-20.24M

---4.08M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-14.73%-6.17M	-120.90%-8.5M	-52.08%-7.98M	196.16%19.35M	-162.61%-10.7M	-5.38M	40.67M	-5.24M	23.40%-20.12M	-4.08M
Net income from continuing operations	-64.25%-10.27M	-121.68%-9.01M	-74.48%-8.42M	193.68%22.72M	-3.42%-7.77M	---6.25M	--41.56M	---4.82M	16.37%-24.25M	---7.51M
Operating gains losses	----	----	387.50%117K	300.00%14K	-166.67%-8K	---2K	--0	--24K	-250.00%-7K	---3K
Depreciation and amortization	44.19%62K	42.86%60K	-16.44%61K	-40.73%195K	-54.32%37K	--43K	--42K	--73K	1.23%329K	--81K
Other non cash items	-1.28%231K	112.26%351K	-7.58%244K	-172.46%-2.1M	-89.65%265K	--234K	---2.86M	--264K	1,667.07%2.9M	--2.56M
Change In working capital	107.15%2.32M	-112.58%-209K	127.12%275K	19.18%-1.02M	-765.87%-2.79M	--1.12M	--1.66M	---1.01M	-1,273.15%-1.27M	--419K
-Change in prepaid assets	135.11%435K	189.13%133K	1,288.33%713K	-237.83%-1.28M	-131.17%-24K	---1.24M	--46K	---60K	-0.53%-378K	--77K
-Change in payables and accrued expense	-30.26%1.87M	-170.16%-1.29M	35.34%-450K	2,244.12%1.59M	-450.63%-2.23M	--2.68M	--1.84M	---696K	-80.90%68K	--636K
-Change in other current assets	101.67%1K	3,127.59%936K	--0	121.88%7K	203.13%33K	---60K	--29K	--5K	-300.00%-32K	---32K
-Change in other current liabilities	104.96%13K	105.12%13K	104.56%12K	-45.73%-1.35M	19.63%-569K	---262K	---254K	---263K	-925.89%-925K	---708K
Cash from discontinued investing activities
Operating cash flow	-14.73%-6.17M	-120.90%-8.5M	-52.08%-7.98M	196.16%19.35M	-162.55%-10.7M	---5.38M	--40.67M	---5.24M	23.40%-20.12M	---4.08M
Investing cash flow
Cash flow from continuing investing activities	23.58%-30.18M	12.50%-38.9M	-6.67%8.73M	-394.04%-65.57M	83.65%9.03M	-39.5M	-44.46M	9.36M	134.32%22.3M	4.92M
Net PPE purchase and sale	-181.82%-62K	-283.87%-119K	-182.69%-147K	-250.85%-414K	---309K	---22K	---31K	---52K	29.76%-118K	--0
Net investment purchase and sale	23.69%-30.12M	12.71%-38.78M	-5.62%8.88M	-390.65%-65.15M	89.93%9.34M	---39.47M	---44.43M	--9.41M	134.59%22.42M	--4.92M
Cash from discontinued investing activities
Investing cash flow	23.58%-30.18M	12.50%-38.9M	-6.67%8.73M	-394.04%-65.57M	83.65%9.03M	---39.5M	---44.46M	--9.36M	134.32%22.3M	--4.92M
Financing cash flow
Cash flow from continuing financing activities	-99.87%13K	131.60%108.36M	97.08%-18K	4,633.98%56.18M	48.64%-321K	10.33M	46.79M	-617K	-101.55%-1.24M	-625K
Net issuance payments of debt	--0	--0	--0	-200.00%-3.75M	--0	--0	---3.13M	---625K	---1.25M	---625K
Net common stock issuance	--0	----	----	-600.00%-28K	---28K	--0	----	----	---4K	--0
Net preferred stock issuance	--0	----	----	--60.14M	--0	--10.24M	----	----	--0	--0
Proceeds from stock option exercised by employees	-84.15%13K	-31.58%13K	1,425.00%122K	960.00%159K	--50K	--82K	--19K	--8K	-86.73%15K	--0
Net other financing activities	----	----	---140K	---343K	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-99.87%13K	131.60%108.36M	97.08%-18K	4,633.98%56.18M	48.64%-321K	--10.33M	--46.79M	---617K	-101.55%-1.24M	---625K
Net cash flow
Beginning cash position	48.32%77.23M	79.45%16.26M	178.79%15.53M	20.28%5.57M	227.25%17.52M	--52.07M	--9.06M	--5.57M	-71.11%4.63M	--5.35M
Current changes in cash	-5.18%-36.34M	41.76%60.97M	-78.88%738K	960.38%9.96M	-1,027.91%-2M	---34.55M	--43.01M	--3.49M	108.24%939K	--215K
End cash Position	133.38%40.89M	48.32%77.23M	79.45%16.26M	178.79%15.53M	178.79%15.53M	--17.52M	--52.07M	--9.06M	20.28%5.57M	--5.57M
Free cash flow	-15.78%-6.25M	-121.20%-8.62M	-53.36%-8.12M	193.56%18.94M	-170.13%-11.01M	---5.4M	--40.64M	---5.3M	23.44%-20.24M	---4.08M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data